medicine
CN → US商品图片
AI分析
💊 Medicine (Pharmaceutical Products)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional-Level Clearance Strategy
📌 I. Product Definition & Classification: Do You Really Understand “Medicine”?
Medicine, in the context of international trade and customs classification, refers to pharmaceutical products intended for therapeutic, prophylactic, or diagnostic purposes. It is a highly regulated category with strict quality standards and specific HS Code classifications based on the form, ingredients, and intended use.
In international trade, medicine is primarily divided into two main categories:
- Prepared Pharmaceutical Products (HS Chapter 30): These are finished drugs, including tablets, capsules, liquids, injectables, creams, and ointments, ready for consumer use. They are classified under Heading 30.04 or 30.06.
- Active Pharmaceutical Ingredients (APIs) & Bulk Drugs: These are the raw chemical substances used to manufacture medicines. They are classified under Heading 29 (e.g., organic chemicals) or Chapter 30 if specifically identified as products of heading 30.01 or 30.02.
⚠️ Key Distinction Points: - Finished Dosage Forms (tablets, capsules, etc.) → HS Code 3004 / 3006 - Bulk Chemicals/APIs (not in measurable doses or retail packaging) → HS Code 29xxxx (specific subheading based on chemical structure) - Vaccines, Blood Products, Hormones → HS Code 3002 - Medical Kits/First Aid Sets → HS Code 3006
📦 II. HS Code Classification Details (2026 Latest Tariff Authority Reference)
| HS Code | Product Description | Application Scenario | Dosage Form/Retail Packaging |
|---|---|---|---|
3004.90.55.00 |
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, in measured doses or put up in retail packaging | Most common OTC and prescription drugs (tablets, capsules, syrups) | ✅ Yes |
3004.10.00.00 |
Medicaments containing penicillins or derivatives thereof, with or without other substances | Antibiotics (Penicillin-based) | ✅ Yes |
3004.20.00.00 |
Medicaments containing streptomycins or their derivatives | Antibiotics (Streptomycin-based) | ✅ Yes |
3004.31.00.00 |
Medicaments containing insulin | Diabetic treatments | ✅ Yes |
3004.32.00.00 |
Medicaments containing hormones or steroids | Hormonal therapies (e.g., cortisone, testosterone) | ✅ Yes |
3004.90.90.00 |
Other medicaments | Miscellaneous drugs not specified above | ✅ Yes |
3002.11.00.00 |
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic purposes | Blood products, plasma, vaccines | ✅ Yes |
2933.39.00.00 |
Heterocyclic compounds with nitrogen heteroatoms only (e.g., some APIs) | Bulk pharmaceutical ingredients (not in dose/retail pack) | ❌ No |
2937.11.00.00 |
Insulin and its derivatives | Bulk insulin (API form) | ❌ No |
🔍 Critical Reminder: - Finished drugs (in measured doses or retail packaging) must be classified under Heading 3004 or 3006. - Bulk APIs (raw chemicals) are often classified under Chapter 29 (Chemical Products), not Chapter 30, unless specifically excluded. - Vaccines and blood products are classified under Heading 3002. - Misclassification can lead to severe penalties, especially for controlled substances or high-tariff APIs.
💰 III. 2026 Latest Tariff Rate Details (Including Surtaxes & Policy Add-ons)
✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Date: November 10, 2025 (including subsequent imports)
🎯 1. 3004.90.55.00 — General Medicaments (Most OTC & Prescription Drugs)
| Item | Content |
|---|---|
| Basic Tariff Rate | 0% (ad valorem) |
| USITC Surtax | +25% (from USITC Footnote 9903.88.01) |
| IEEPA Surtax | +10% (against Chinese/Hong Kong products, effective Nov 10, 2025) |
| Total Tariff Rate | 35% |
| Tax Calculation | CIF Value × 35% |
| De Minimis Exemption Available? | ❌ No (deny_de_minimis) |
| Legal Basis Path | IEEPA:9903.01.25 → IEEPA:9903.01.24 → USITC:3004.90.55.00 → FOOTNOTE:9903.88.01 |
📌 Explanation: - The “25% USITC Surtax” stems from Section 301 tariffs under the U.S. Trade Act. - The “10% IEEPA Surtax” is an additional duty against Chinese-origin goods. - Total 35% is a high tariff rate, requiring advance planning!
🎯 2. 3004.10.00.00 — Penicillin-Based Medicaments
| Item | Content |
|---|---|
| Basic Tariff Rate | 0% |
| USITC Surtax | +25% |
| IEEPA Surtax | +10% |
| Total Tariff Rate | 35% |
| Tax Calculation | CIF × 35% |
| De Minimis Exemption Available? | ❌ No |
| Legal Basis Path | IEEPA:9903.01.25 → IEEPA:9903.01.24 → USITC:3004.10.00.00 → FOOTNOTE:9903.88.01 |
📌 Note: - Same tax structure as general medicaments. - Applies to all penicillin-based drugs, regardless of dosage form.
🎯 3. 3002.11.00.00 — Human Blood / Blood Products
| Item | Content |
|---|---|
| Basic Tariff Rate | 0% |
| USITC Surtax | +25% |
| IEEPA Surtax | +10% |
| Total Tariff Rate | 35% |
| Tax Calculation | CIF × 35% |
| De Minimis Exemption Available? | ❌ No |
📌 Note: - Blood products and vaccines are subject to the same surtaxes. - These goods require FDA approval and import licenses.
🛠️ IV. Customs Clearance Practical Advice (Real-World Pitfall Avoidance Guide)
✅ 1. Documentation Checklist (None Can Be Missing)
| Document | Required | Description |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Includes dosage, active ingredients, concentration, route of administration |
| ✅ Certificate of Analysis (CoA) | ✔️ | Verifies purity, potency, and quality standards |
| ✅ FDA Import Prior Notice | ✔️ | Mandatory for drugs entering the U.S. |
| ✅ FDA Drug Listing & Registration | ✔️ | Establishes facility and product registration |
| ✅ Commercial Invoice | ✔️ | Clearly states “Pharmaceutical Product, [HS Code]” |
| ✅ Certificate of Origin (CO) | ✔️ | If non-Chinese origin, may qualify for reduced tariffs |
| ✅ Packing List | ✔️ | Details inner/outer packaging, batch numbers, expiration dates |
| ✅ FDA Prior Notice Confirmation | ✔️ | Must be submitted before arrival |
✅ 2. Declaration Tips (Key Mantra)
🔥 “Finished drugs go to 3004, APIs go to 29, vaccines to 3002, and misclassification brings fines!”
| Scenario | Correct Declaration Method | Incorrect Practice |
|---|---|---|
| Finished Tablets/Capsules | 3004.90.55.00 |
Misdeclare as “Chemicals” → 35% + penalties |
| Bulk API (Raw Powder) | 29xxxx (e.g., 2933.39.00) |
Misdeclare as “Finished Drug” → 35% + FDA hold |
| Vaccines | 3002.11.00.00 |
Misdeclare as “Medicament” → 35% + FDA rejection |
| Medical Kits | 3006 |
Misdeclare as “Drugs” → 35% + inspection delay |
✅ 3. Special Case Handling
| Scenario | Handling Advice |
|---|---|
| OEM/Private Label Drugs | Provide contract, manufacturing authorization, and FDA registration proof |
| Controlled Substances | Require DEA Importer Registration and Controlled Substance Import Permit |
| Biologics (Vaccines, Insulin) | Require Biologics License Application (BLA) and FDA Prior Notice |
| Drugs for Personal Use | May qualify for de minimis if < $800, but not for commercial shipments |
| Expired or Recalled Drugs | Prohibited from import; may result in seizure and fines |
🌍 V. Global Major Market Clearance Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff | Certification Requirements | Remarks |
|---|---|---|---|---|
| 🇺🇸 United States | 3004.90.55.00 |
35% (China origin) | FDA + Prior Notice | High regulation; 35% tariff |
| 🇨🇳 China | 3004.90.55.00 |
0% | NMPA (formerly CFDA) | No surtaxes |
| 🇪🇺 European Union | 3004 |
0% (if CE/GMP) | EMA + GMP + CEP | Free trade within EU |
| 🇦🇺 Australia | 3004 |
5% | TGA | No surtaxes |
| 🇯🇵 Japan | 3004 |
0% | PMDA | No surtaxes |
📌 Conclusion: - The U.S. is the only major market imposing high surtaxes on Chinese pharmaceutical products. - China-origin drugs face 35% tariffs in the U.S., making pre-clearance planning essential. - EU, Japan, Australia have lower or zero tariffs but require strict GMP/EMA/TGA approvals.
📌 VI. Common Errors & Pitfall Avoidance (Lessons from Real Cases)
❌ Error 1: Declaring finished tablets as “Chemicals” (Chapter 29)
👉 Consequence: 35% tariff + FDA rejection + fines
❌ Error 2: Failing to submit FDA Prior Notice before arrival
👉 Consequence: Shipment held at port; potential return or destruction
❌ Error 3: Misclassifying bulk APIs as finished drugs
👉 Consequence: Unnecessary 35% tariff + quality inspection delays
❌ Error 4: Using vague descriptions like “Medicine” or “Drug” without HS Code
👉 Consequence: Customs may misclassify, leading to penalties and delays
✅ Correct Practice:
“Paracetamol Tablets, 500mg, 100 tablets/blister, for oral use, FDA-approved, HS Code 3004.90.55.00”
🎯 VII. Conclusion: Professional Declaration Saves Time, Money, and Risk
🎯 Remember the Mantra:
🔹 “Finished drugs → 3004, APIs → 29, vaccines → 3002, and misclassification brings fines!”
🔹 “HS Code determines tariff, tariff determines cost, and correct declaration saves thousands!”
📌 Pro Tip:
If your pharmaceutical products originate from Vietnam, India, Malaysia, or Thailand, you may qualify for IEEPA exemptions, reducing the tariff to 0%~5%.
Recommendation: Apply for an Advance Ruling from U.S. Customs and Border Protection (CBP) to avoid clearance risks.
📣 Immediate Action:
📞 Contact a licensed customs broker + Provide FDA documentation + Apply for HS Code Advance Ruling
🚀 Ensure your pharmaceutical products clear customs smoothly, efficiently, and cost-effectively!
✨ Professional Clearance Starts with Accurate Classification!
💼 Every cent of cost deserves precise calculation!
用户评价
关于 HS 编码归类
协调制度（HS）是由世界海关组织（WCO）制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构：
- 章（2 位）——商品大类（例如：第 84 章：机器和机械设备）
- 品目（4 位）——章内的更具体分类
- 子目（6 位）——国际通用细分，所有 WCO 成员国统一使用
- 本国细分（8-10 位）——各国自行扩展的细分编码，如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时，适用的关税税率可能包括：
- 最惠国（MFN）税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税，如 301 条款（反倾销）、232 条款（国家安全）或反补贴税
本页内容仅供参考。如需正式归类，请咨询当地海关或持牌报关代理。